Profound Medical Corp. Form 6-K Summary
Business Context and Reporting Period
Profound Medical Corp., a foreign private issuer, filed this Form 6-K on December 16, 2024, for the month of December 2024. The filing serves to report a material change pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The registrant's principal executive office is located in Mississauga, Ontario.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a cover sheet referencing an attached exhibit rather than a financial statement.
Material Changes
The filing incorporates by reference Exhibit 99.1, titled "Material Change Report, dated December 16, 2024." The specific nature of the material change is not detailed within the cover text of this Form 6-K.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or details regarding contingencies and unusual items. These details are expected to be contained within the referenced Material Change Report (Exhibit 99.1).
Key Facts for Investor Verification
- Review the attached Exhibit 99.1 (Material Change Report) to understand the specific event triggering this filing.
- Verify the date of the material change, which is listed as December 16, 2024.
- Confirm the identity of the signatory, Rashed Dewan, Chief Financial Officer, who authorized the report.
- Note that this filing does not include audited or unaudited financial data; investors must refer to the company's most recent Form 20-F or interim reports for financial metrics.